Skip to primary navigation
Skip to main content
Skip to footer
Fractyl Health
Transformative Metabolic Therapies
Investors
Clinical Studies
Careers
Our Focus
Obesity
Type 2 Diabetes
Our Platforms
Revita
Rejuva
Our Science
Clinical Studies
Presentations & Publications
Our Company
Culture
Our Team
Careers
Our News
Media Kit
Home
/
Type 2 diabetes
A prospective post-market clinical follow-up registry to evaluate real-world effectiveness and patient satisfaction after duodenal mucosal resurfacing in patients with type 2 diabetes
Type 2 diabetes
October 5, 2024
by
Our Focus
Obesity
Type 2 Diabetes
Our Platforms
Revita
Rejuva
Our Science
Clinical Studies
Presentations & Publications
Our Company
Culture
Our Team
Careers
Our News
Media Kit
Investors
